Yigal Nochomovitz
Stock Analyst at Citi
(3.96)
# 1,848
Out of 5,128 analysts
845
Total ratings
43.7%
Success rate
4.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $20 → $23 | $13.07 | +75.98% | 18 | Nov 11, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $184 → $194 | $93.33 | +107.86% | 6 | Nov 11, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $39 → $44 | $26.47 | +66.23% | 38 | Nov 11, 2026 | |
| ATTO Attovia Therapeutics | Reiterated: Buy | $30 → $34 | $15.81 | +115.05% | 4 | Nov 10, 2026 | |
| BMEA Biomea Fusion | Reiterated: Buy | $7 | $0.5627 | +1,144.00% | 22 | Nov 10, 2026 | |
| OLMA Olema Pharmaceuticals | Reiterated: Buy | $59 | $7.52 | +684.57% | 17 | Nov 10, 2026 | |
| LXRX Lexicon Pharmaceuticals | Reiterated: Buy | $3.1 → $3.4 | $1.82 | +86.81% | 37 | Nov 9, 2026 | |
| RIGL Rigel Pharmaceuticals | Reiterated: Buy | $83 → $86 | $45.69 | +88.22% | 20 | Nov 9, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Sell | $13 | $16.01 | -18.80% | 15 | Nov 9, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | $90 | $42.62 | +111.17% | 29 | Nov 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $22 | $16.27 | +35.22% | 34 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $66 | $31.49 | +109.59% | 22 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $14.31 | +46.75% | 3 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $4.09 | +120.05% | 16 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $397 → $402 | $316.27 | +27.11% | 8 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $15.08 | +185.24% | 25 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $17.77 | +181.37% | 34 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $416 → $412 | $305.68 | +34.78% | 14 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 | $9.54 | +497.48% | 21 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.13 | +73.87% | 7 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $1.15 | +595.65% | 8 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $27.64 | +73.66% | 15 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $4 | $0.3195 | +1,151.96% | 6 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $466 | $415.96 | +12.03% | 9 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $26.04 | +72.81% | 29 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $15.02 | +206.26% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $33 | $18.14 | +81.92% | 10 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $8.44 | +136.97% | 22 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.00 | +100.00% | 8 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 → $253 | $169.40 | +49.35% | 12 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $0.3802 | +2,004.16% | 23 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.81 | +274.22% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.12 | +252.56% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $21 | $6.87 | +205.68% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $85 | $51.56 | +64.86% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $8.39 | +209.89% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $8.50 | +88.24% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $13.36 | -32.63% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $33.32 | +26.05% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.36 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $11 | $1.33 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $0.5385 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $0.02185 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $2.29 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $1.2 | $2.55 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.34 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.6301 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $35 → $10 | $7.93 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $8 | $1.49 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.4 → $0.25 | $12.48 | n/a | 9 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $63.36 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $2 | $0.93 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €1.33 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $48.31 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $8.08 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $1.10 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $0.498 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.000001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.44 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $1.25 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $6.28 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.28 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.03 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,623.00 | n/a | 3 | Nov 21, 2014 |
ArriVent BioPharma
Nov 11, 2026
Reiterated: Buy
Price Target: $20 → $23
Current: $13.07
Upside: +75.98%
Mirum Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $184 → $194
Current: $93.33
Upside: +107.86%
Zymeworks
Nov 11, 2026
Reiterated: Buy
Price Target: $39 → $44
Current: $26.47
Upside: +66.23%
Attovia Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $15.81
Upside: +115.05%
Biomea Fusion
Nov 10, 2026
Reiterated: Buy
Price Target: $7
Current: $0.5627
Upside: +1,144.00%
Olema Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $59
Current: $7.52
Upside: +684.57%
Lexicon Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $3.1 → $3.4
Current: $1.82
Upside: +86.81%
Rigel Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $83 → $86
Current: $45.69
Upside: +88.22%
Sarepta Therapeutics
Nov 9, 2026
Reiterated: Sell
Price Target: $13
Current: $16.01
Upside: -18.80%
CRISPR Therapeutics AG
Nov 8, 2026
Reiterated: Buy
Price Target: $90
Current: $42.62
Upside: +111.17%
Nov 6, 2026
Reiterated: Buy
Price Target: $32 → $22
Current: $16.27
Upside: +35.22%
Nov 5, 2026
Reiterated: Buy
Price Target: $65 → $66
Current: $31.49
Upside: +109.59%
Nov 5, 2026
Reiterated: Buy
Price Target: $21
Current: $14.31
Upside: +46.75%
Nov 5, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $4.09
Upside: +120.05%
Nov 5, 2026
Reiterated: Buy
Price Target: $397 → $402
Current: $316.27
Upside: +27.11%
Nov 5, 2026
Reiterated: Buy
Price Target: $43
Current: $15.08
Upside: +185.24%
Nov 4, 2026
Reiterated: Buy
Price Target: $50
Current: $17.77
Upside: +181.37%
Nov 3, 2026
Reiterated: Buy
Price Target: $416 → $412
Current: $305.68
Upside: +34.78%
Nov 2, 2026
Reiterated: Buy
Price Target: $57
Current: $9.54
Upside: +497.48%
Nov 2, 2026
Reiterated: Buy
Price Target: $35
Current: $20.13
Upside: +73.87%
Oct 28, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $1.15
Upside: +595.65%
Oct 27, 2026
Reiterated: Buy
Price Target: $48
Current: $27.64
Upside: +73.66%
Oct 20, 2026
Reiterated: Buy
Price Target: $17 → $4
Current: $0.3195
Upside: +1,151.96%
Oct 19, 2026
Reiterated: Buy
Price Target: $466
Current: $415.96
Upside: +12.03%
Oct 19, 2026
Reiterated: Buy
Price Target: $45
Current: $26.04
Upside: +72.81%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $15.02
Upside: +206.26%
Sep 25, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $18.14
Upside: +81.92%
Sep 24, 2026
Upgraded: Buy
Price Target: $8 → $20
Current: $8.44
Upside: +136.97%
Sep 10, 2026
Reiterated: Buy
Price Target: $14
Current: $7.00
Upside: +100.00%
Sep 4, 2026
Reiterated: Buy
Price Target: $249 → $253
Current: $169.40
Upside: +49.35%
Aug 13, 2026
Rated: Buy
Price Target: $8
Current: $0.3802
Upside: +2,004.16%
Aug 12, 2026
Reiterated: Buy
Price Target: $18
Current: $4.81
Upside: +274.22%
Aug 10, 2026
Reiterated: Buy
Price Target: $14 → $11
Current: $3.12
Upside: +252.56%
Aug 10, 2026
Reiterated: Buy
Price Target: $24 → $21
Current: $6.87
Upside: +205.68%
Aug 6, 2026
Reiterated: Buy
Price Target: $70 → $85
Current: $51.56
Upside: +64.86%
Jun 30, 2026
Reiterated: Buy
Price Target: $26
Current: $8.39
Upside: +209.89%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $8.50
Upside: +88.24%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $13.36
Upside: -32.63%
Mar 9, 2026
Reiterated: Buy
Price Target: $42
Current: $33.32
Upside: +26.05%
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.36
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $16 → $11
Current: $1.33
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $0.5385
Upside: n/a
Sep 12, 2024
Reiterated: Buy
Price Target: $12 → $10
Current: $0.02185
Upside: n/a
Aug 15, 2024
Reiterated: Buy
Price Target: $16 → $14
Current: $2.29
Upside: n/a
Jun 17, 2024
Reiterated: Hold
Price Target: $3.5 → $1.2
Current: $2.55
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $10
Current: $1.34
Upside: n/a
Dec 4, 2023
Reiterated: Buy
Price Target: $8
Current: $0.6301
Upside: n/a
Nov 22, 2023
Reiterated: Sell
Price Target: $35 → $10
Current: $7.93
Upside: n/a
Sep 18, 2023
Reiterated: Buy
Price Target: $12 → $8
Current: $1.49
Upside: n/a
Aug 29, 2023
Reiterated: Hold
Price Target: $0.4 → $0.25
Current: $12.48
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $63.36
Upside: n/a
Nov 28, 2022
Reiterated: Buy
Price Target: $5 → $2
Current: $0.93
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: €12.00
Current: €1.33
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $48.31
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $8.08
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $1.10
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $0.498
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $8.44
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $32
Current: $1.25
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $6.28
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $1.28
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $8.03
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,623.00
Upside: n/a